Sanofi has to divest some OTC lines in Europe

9 August 2016 - Deborah Wilkes

Archived

The European Commission has approved Sanofi's planned acquisition of Boehringer Ingelheim's Consumer Health Care business, provided some OTC brands are divested in a number of countries.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: